Spotlight on global cancer control at ASCO 2022
Spotlight on global cancer control at ASCO 2022
Biomarker analysis of the NeoALTTO trial provides oncofertility insight for younger breast cancer patients
Adjuvant endocrine therapy used to treat ER+ HER2- breast cancer
Safety follow-up of the randomized, phase 3 study DESTINY-Breast03
Lenalidomide, bortezomib, and dexamethasone ASCT to progress for NDMM: Phase 3 DETERMINATION trial
Circulating tumour DNA analysis can help identify the need for adjuvant therapy in stage II colon cancer
Cancer Services Delivery: Focus on India
War in Ukraine: Impacts on the Slovakian cancer care system
Inspiration Family: Challenges of the Ukrainian cancer charity on the frontline
War in Ukraine: Impacts on the Polish cancer care system and vaccination challenges
War in Ukraine: Current and future impacts on the Romanian cancer care system
Lymphoma Coalition: Challenges for Ukrainian haematological cancer patients